- call +1-201-465-4211
- email sales@marketresearchplace.com
In 2018, the global Pharmacovigilance (PV) market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Pharmacovigilance (PV) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacovigilance (PV) development in United States, Europe and China.
The key players covered in this study
Accenture
Clinquest Group B.V.
Cognizant
Laboratory Corporation of America Holdings
IBM Corporation
ArisGlobal
ICON plc.
Capgemini
ITClinical
iMEDGlobal
Foresight Group International AG
TAKE Solutions Ltd.
PAREXEL International Corporation
BioClinica
Wipro Ltd.
United BioSource Corporation
Market segment by Type, the product can be split into
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Market segment by Application, split into
Hospitals
Research Organizations
Industrial
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Pharmacovigilance (PV) status, future forecast, growth opportunity, key market and key players.
To present the Pharmacovigilance (PV) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Pharmacovigilance (PV) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pharmacovigilance (PV) Market Size Growth Rate by Type (2014-2025)
1.4.2 Spontaneous Reporting
1.4.3 Intensified ADR Reporting
1.4.4 Targeted Spontaneous Reporting
1.4.5 Cohort Event Monitoring
1.4.6 EHR Mining
1.5 Market by Application
1.5.1 Global Pharmacovigilance (PV) Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Research Organizations
1.5.4 Industrial
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Pharmacovigilance (PV) Market Size
2.2 Pharmacovigilance (PV) Growth Trends by Regions
2.2.1 Pharmacovigilance (PV) Market Size by Regions (2014-2025)
2.2.2 Pharmacovigilance (PV) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Pharmacovigilance (PV) Market Size by Manufacturers
3.1.1 Global Pharmacovigilance (PV) Revenue by Manufacturers (2014-2019)
3.1.2 Global Pharmacovigilance (PV) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pharmacovigilance (PV) Market Concentration Ratio (CR5 and HHI)
3.2 Pharmacovigilance (PV) Key Players Head office and Area Served
3.3 Key Players Pharmacovigilance (PV) Product/Solution/Service
3.4 Date of Enter into Pharmacovigilance (PV) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Pharmacovigilance (PV) Market Size by Type (2014-2019)
4.2 Global Pharmacovigilance (PV) Market Size by Application (2014-2019)
5 United States
5.1 United States Pharmacovigilance (PV) Market Size (2014-2019)
5.2 Pharmacovigilance (PV) Key Players in United States
5.3 United States Pharmacovigilance (PV) Market Size by Type
5.4 United States Pharmacovigilance (PV) Market Size by Application
6 Europe
6.1 Europe Pharmacovigilance (PV) Market Size (2014-2019)
6.2 Pharmacovigilance (PV) Key Players in Europe
6.3 Europe Pharmacovigilance (PV) Market Size by Type
6.4 Europe Pharmacovigilance (PV) Market Size by Application
7 China
7.1 China Pharmacovigilance (PV) Market Size (2014-2019)
7.2 Pharmacovigilance (PV) Key Players in China
7.3 China Pharmacovigilance (PV) Market Size by Type
7.4 China Pharmacovigilance (PV) Market Size by Application
8 Japan
8.1 Japan Pharmacovigilance (PV) Market Size (2014-2019)
8.2 Pharmacovigilance (PV) Key Players in Japan
8.3 Japan Pharmacovigilance (PV) Market Size by Type
8.4 Japan Pharmacovigilance (PV) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Pharmacovigilance (PV) Market Size (2014-2019)
9.2 Pharmacovigilance (PV) Key Players in Southeast Asia
9.3 Southeast Asia Pharmacovigilance (PV) Market Size by Type
9.4 Southeast Asia Pharmacovigilance (PV) Market Size by Application
10 India
10.1 India Pharmacovigilance (PV) Market Size (2014-2019)
10.2 Pharmacovigilance (PV) Key Players in India
10.3 India Pharmacovigilance (PV) Market Size by Type
10.4 India Pharmacovigilance (PV) Market Size by Application
11 Central & South America
11.1 Central & South America Pharmacovigilance (PV) Market Size (2014-2019)
11.2 Pharmacovigilance (PV) Key Players in Central & South America
11.3 Central & South America Pharmacovigilance (PV) Market Size by Type
11.4 Central & South America Pharmacovigilance (PV) Market Size by Application
12 International Players Profiles
12.1 Accenture
12.1.1 Accenture Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pharmacovigilance (PV) Introduction
12.1.4 Accenture Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.1.5 Accenture Recent Development
12.2 Clinquest Group B.V.
12.2.1 Clinquest Group B.V. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pharmacovigilance (PV) Introduction
12.2.4 Clinquest Group B.V. Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.2.5 Clinquest Group B.V. Recent Development
12.3 Cognizant
12.3.1 Cognizant Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pharmacovigilance (PV) Introduction
12.3.4 Cognizant Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.3.5 Cognizant Recent Development
12.4 Laboratory Corporation of America Holdings
12.4.1 Laboratory Corporation of America Holdings Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pharmacovigilance (PV) Introduction
12.4.4 Laboratory Corporation of America Holdings Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.4.5 Laboratory Corporation of America Holdings Recent Development
12.5 IBM Corporation
12.5.1 IBM Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pharmacovigilance (PV) Introduction
12.5.4 IBM Corporation Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.5.5 IBM Corporation Recent Development
12.6 ArisGlobal
12.6.1 ArisGlobal Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pharmacovigilance (PV) Introduction
12.6.4 ArisGlobal Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.6.5 ArisGlobal Recent Development
12.7 ICON plc.
12.7.1 ICON plc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pharmacovigilance (PV) Introduction
12.7.4 ICON plc. Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.7.5 ICON plc. Recent Development
12.8 Capgemini
12.8.1 Capgemini Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pharmacovigilance (PV) Introduction
12.8.4 Capgemini Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.8.5 Capgemini Recent Development
12.9 ITClinical
12.9.1 ITClinical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pharmacovigilance (PV) Introduction
12.9.4 ITClinical Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.9.5 ITClinical Recent Development
12.10 iMEDGlobal
12.10.1 iMEDGlobal Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pharmacovigilance (PV) Introduction
12.10.4 iMEDGlobal Revenue in Pharmacovigilance (PV) Business (2014-2019)
12.10.5 iMEDGlobal Recent Development
12.11 Foresight Group International AG
12.12 TAKE Solutions Ltd.
12.13 PAREXEL International Corporation
12.14 BioClinica
12.15 Wipro Ltd.
12.16 United BioSource Corporation
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Pharmacovigilance (PV) Key Market Segments
Table Key Players Pharmacovigilance (PV) Covered
Table Global Pharmacovigilance (PV) Market Size Growth Rate by
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
